- Filed
- May 12, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 1.22B sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 1.22B sh |
| Shares Outstanding restated | Q1 2026 · Mar 31, 2026 | 1.22B sh |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$126.43K |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | −$5.22K |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $111.27K |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $263.15K |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $13.96M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $14.06M |
| Stockholders Equity | Q1 2026 · Mar 31, 2025 | $14.08M |
| Stockholders Equity | Q1 2026 · Dec 31, 2024 | $14.09M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $4.2M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $4.26M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $4.2M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $4.26M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $18.16M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $18.32M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $18.16M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $18.32M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | $0.00 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | $0.00 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | $0.00 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | $0.00 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $89.96K |
| Sga Expense | Q1 2026 · Mar 31, 2025 | $5.22K |
| Net Income | Q1 2026 · Mar 31, 2026 | −$97.33K |
| Net Income | Q1 2026 · Mar 31, 2025 | −$5.22K |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$89.96K |
| Operating Income | Q1 2026 · Mar 31, 2025 | −$5.22K |